全文获取类型
收费全文 | 1743篇 |
免费 | 157篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 94篇 |
妇产科学 | 16篇 |
基础医学 | 208篇 |
口腔科学 | 32篇 |
临床医学 | 147篇 |
内科学 | 350篇 |
皮肤病学 | 43篇 |
神经病学 | 48篇 |
特种医学 | 159篇 |
外科学 | 228篇 |
综合类 | 149篇 |
预防医学 | 128篇 |
眼科学 | 14篇 |
药学 | 160篇 |
中国医学 | 39篇 |
肿瘤学 | 100篇 |
出版年
2023年 | 9篇 |
2022年 | 17篇 |
2021年 | 27篇 |
2020年 | 24篇 |
2019年 | 22篇 |
2018年 | 28篇 |
2017年 | 19篇 |
2016年 | 25篇 |
2015年 | 36篇 |
2014年 | 53篇 |
2013年 | 52篇 |
2012年 | 64篇 |
2011年 | 78篇 |
2010年 | 94篇 |
2009年 | 72篇 |
2008年 | 54篇 |
2007年 | 55篇 |
2006年 | 73篇 |
2005年 | 58篇 |
2004年 | 47篇 |
2003年 | 54篇 |
2002年 | 45篇 |
2001年 | 55篇 |
2000年 | 54篇 |
1999年 | 53篇 |
1998年 | 59篇 |
1997年 | 67篇 |
1996年 | 58篇 |
1995年 | 49篇 |
1994年 | 39篇 |
1993年 | 37篇 |
1992年 | 25篇 |
1991年 | 25篇 |
1990年 | 26篇 |
1989年 | 40篇 |
1988年 | 32篇 |
1987年 | 38篇 |
1986年 | 31篇 |
1985年 | 30篇 |
1984年 | 24篇 |
1983年 | 13篇 |
1982年 | 19篇 |
1981年 | 13篇 |
1980年 | 22篇 |
1979年 | 11篇 |
1977年 | 12篇 |
1976年 | 9篇 |
1975年 | 11篇 |
1972年 | 10篇 |
1971年 | 8篇 |
排序方式: 共有1918条查询结果,搜索用时 15 毫秒
31.
Thrombocytopoietic properties of oncostatin M 总被引:1,自引:2,他引:1
Oncostatin M (OM) is a 28-kD glycoprotein that exhibits a panoply of biologic effects. Based on histologic observations of increased splenic megakaryocytes in nude mice implanted with an OM-secreting cell line, the thrombocytopoietic properties of OM in mice were investigated in culture and in vivo. Alone, OM did not induce megakaryocytic colony formation, but in combination with murine interleukin-3 (IL-3), OM markedly enhanced colony formation. The effects of OM on colony formation were similar to those of IL-6. OM alone augmented acetylcholinesterase in short-term marrow cultures. In normal mice, the administration of OM augmented platelet counts without increasing other circulating blood cell counts. The increment in counts exceeded that observed with IL-6. The kinetics of the OM response suggested that maximal increases in platelets occurred 3 days after the cessation of OM administration, irrespective of the duration of administration. In irradiated mice, OM administration accelerated platelet recovery and prevented the decrease in red blood cells observed in irradiated control animals. The data show that OM behaves as a megakaryocytic maturation factor in vitro and augments platelet production in vivo. Based on these animal data, OM may have potential clinical utility as a thrombocytopoietic agent. 相似文献
32.
It has previously been shown that monolayer cultures derived adherent cells (MDAC), apparently consisting of fibroblasts, macrophages, epithelioid cells, and fat cells, can support long-term stem cell proliferation in vitro. In the present study, the hematopoietic support capability of murine MDAC monolayers was confirmed and the cultured cells further characterized with respect to the following properties: esterase I activity, complement (C3) receptors, IgG (Fc) receptors, colony stimulating activity (csa) production, and collagen synthesis. The cultures were also examined immunohistochemically to localize fibronectin, laminin, and collagen synthesis and to identify the collagen subtypes synthesized. MDAC morphology was as described in previous studies, although fat cells were few in number. It was found that MDAC included some cells with esterase I activity and C3 receptors. Fc receptors were not, however, detected, nor did the cultures produce csa, indicating that mononuclear phagocytes were not present. MDAC synthesized collagen types I and III and also fibronectin. Staining for epithelial basement membrane proteins (collagen types IV and V and laminin) was negative. The results indicate that the vast majority of these cultured MDAC were fibroblasts. 相似文献
33.
Laplace transform analysis of arterial Doppler waveforms was examined for its potential in identifying subjects with early, pre-symptomatic arterial disease. Ninety men, aged 45 to 62, and with no history of cardiovascular disease, were selected from a population of 2300 involved in a longitudinal study of risk factors for cardiovascular disease. Forty-nine were selected on the basis of high values of Laplace delta, omega o, or both, and 41 were selected with "normal" values. Three years after initial screening examination, each was examined clinically and by exercise testing for evidence of arterial disease, and the waveform recordings were repeated. In the group with high waveform analysis values initially, 11 of 49 (22%) were found to have signs of arterial disease 3 years later, while among those with lower values only 2 of 41 (5%) had evidence of disease (p less than 0.05). Although variability of results obviates their use in monitoring the progress of individual subjects, this study supports the potential of Doppler waveform analysis for identifying a group of subjects with a high incidence of early arterial disease. 相似文献
34.
N Senst M Llacuachaqui J Lubinski H Lynch S Armel S Neuhausen P Ghadirian P Sun SA Narod 《Clinical genetics》2013,84(1):43-46
The objective is to estimate the risk of breast cancer in women who carry a deleterious BRCA1 or BRCA2 mutation, according to parental origin of mutation. We conducted a cohort study of women with a BRCA1 mutation (n = 1523) or BRCA2 mutation (n = 369) who had not been diagnosed with breast or ovarian cancer. For each woman, the pedigree was reviewed and the origin of the mutation was assigned as probable paternal or maternal. The hazard ratio (HR) for developing breast cancer in the follow‐up period was estimated for women with a paternal mutation compared to a maternal mutation. The risk of breast cancer was modestly higher in women with a paternal BRCA1 mutation compared to women with a maternal BRCA1 mutation (HR = 1.46; 95% CI = 0.99–2.16) but the difference was not significant (p = 0.06). The parental mutation origin did not affect the risk in women with a BRCA2 mutation. Our results are consistent with the hypothesis that there is an increased risk of breast cancer among women with a paternally inherited BRCA1 mutation compared to a maternally inherited mutation. However, the data are not sufficiently compelling to justify different screening recommendations for the two subgroups. 相似文献
35.
36.
In two previous studies, we observed that recombinant human interleukin- 3 (IL-3) induced an increase in marrow burst-forming unit-erythroid- derived colonies in vitro in some patients with Diamond-Blackfan anemia (DBA). To determine whether a similar erythropoietic response could be induced in vivo, we treated 13 patients with DBA (aged 4 to 19 years) with two preparations of IL-3. All patients had absent absolute reticulocyte counts and markedly reduced to absent recognizable bone marrow erythroid elements; patients with circulating reticulocytes in the previous 12 months were excluded from study. All patients except 1 had failed steroid therapy and had been transfusion-dependent since infancy; 1 patient was maintained on high-dose prednisone at the time of enrollment. On the first arm of the study, IL-3 (Immunex Corp, Seattle, WA) was administered subcutaneously using a dose escalation regimen of 125 to 500 micrograms/m2/day in divided dosage at 12-hour intervals, coadministered with 1.5 mg/kg/d of oral ferrous sulphate. Of the 13 patients that entered the trial, 4 stopped prematurely because of adverse side effects. In the other 9 evaluable cases, reticulocytes increased transiently in 1 patient from 0 to 65 x 10(9)/L after 35 days of IL-3 therapy at 250 micrograms/m2, but transfusion dependency persisted. One transient peak in absolute reticulocyte count was noted in 6 other patients, but no erythroid response was observed after completion of a full course of IL-3. Oral prednisone at 0.5 mg/kg/d was then coadministered with IL-3 at 500 micrograms/m2 to 5 of the patients without effect, and treatment was stopped. In 2 patients, a second preparation of IL-3 (Sandoz Canada Inc, Dorval, Quebec, Canada) was initiated in a dose escalation regimen of 2.5 to 10 micrograms/kg and was coadministered with ferrous sulphate. No erythroid response was observed in either patient, and in one of the two, alternate-day subcutaneous recombinant erythropoietin at 300 U/kg was administered for 3 weeks in combination with daily IL-3 at 10 micrograms/kg, but no increased erythropoiesis was seen. Significant increases in white blood cell and eosinophil counts during administration of both preparations of IL-3 were observed in all patients. These data show that the response of DBA patients to IL-3 in vivo is heterogeneous and cannot be predicted from in vitro studies. The absence of a corrective effect of IL-3 in these patients with DBA indicates that a deficiency of the cytokine is not central in the pathogenesis of the disorder. 相似文献
37.
甲状腺术后瘢痕组织是甲状腺局部分切除术后由于手术方式及缝线填充而形成的组织,甲状腺术后瘢痕组织形成及其发生发展过程同一般的组织损伤修复病理过程一样,为渐进老化阶段的结缔组织,其内小血管稀少,胶原纤维增多[1]。由于甲状腺术后瘢痕组织其质地较硬,活动性差,超声声像图上表现缺乏典型特征,与癌灶极其相似,因此鉴别较困难。本文将介绍超声对于甲状腺术后的随诊应用,分析甲状腺术后瘢痕组织的超声检查特点并着重介绍超声动态观察甲状腺术后瘢痕组织的应用及其发展前景。 相似文献
38.
39.
40.
摘要:目的 探讨白花蛇舌草-半枝莲药对组分对结肠腺癌Lovo细胞增殖、侵袭、迁移和凋亡的影响及作用机制。方法 将白花蛇舌草、半枝莲按质量1∶1进行3次煎煮,获得水提物,后取适量浸膏用石油醚回流脱脂,再以乙酸乙酯进行多次萃取,获得白花蛇舌草-半枝莲药对组分,并计算得率。实验分为对照组(正常培养Lovo细胞)、白花蛇舌草-半枝莲药对组分低剂量组(10 mg/L)、中剂量组(30 mg/L)及高剂量组(50 mg/L)。通过噻唑蓝比色法(MTT)检测各组细胞培养24、48、72 h后的增殖抑制率。各组细胞培养48 h后,流式细胞仪检测细胞周期分布;Transwell实验检测细胞侵袭能力;划痕实验检测细胞迁移能力;TUNEL法检测细胞凋亡情况;Western blot法检测Grb2相关结合蛋白1(Gab1)、血管内皮生长因子受体2(VEGFR-2)、磷脂酰肌醇3-激酶(PI3K)、苏氨酸激酶(Akt)、基质金属蛋白酶-9(MMP-9)、B淋巴细胞瘤-2基因(Bcl-2)、Bcl-2相关X蛋白(Bax)蛋白表达情况。结果 化学萃取后的白花蛇舌草-半枝莲药对中主要含有对羟基苯乙酮、野黄芩苷、木犀草素和芹菜素4种化合物,组分得率为0.61%。与对照组相比,低、中、高剂量组细胞增殖抑制率升高,G1期肿瘤细胞比例增加,细胞凋亡指数增高,侵袭细胞数和划痕闭合率明显减小(均P<0.05),细胞中Gab1、VEGFR-2、PI3K、Akt、MMP-9、Bcl-2蛋白表达降低,Bax表达升高(均P<0.05),且存在剂量依赖性。结论 白花蛇舌草-半枝莲药对组分可抑制结肠腺癌Lovo细胞的增殖,降低其迁移和侵袭能力,诱导细胞凋亡,其机制可能与抑制Gab1/VEGFR-2/PI3K/Akt信号通路活化有关。 相似文献